Aimbe Public Policy Institute

Learn from Washington Insiders about how public policy impacts biomedical engineering!

White House Official Robbie Barbero, Ph.D., Assistant Director for Biological Innovation for the Office of Science and Technology Policy address the White House Role in Science Policymaking.

Participants network with Philip Desjardins, J.D., Vice President of Global Regulatory Affairs & Intelligence for Medical Devices at Johnson & Johnson.

The AIMBE FDA Scholars discuss regulatory policy with Patricia Shrader, J.D., Vice President of Global Regulatory Affairs for Medtronic.


This institute is open to current undergraduate and graduate students, post docs, and early career fellows (including executive branch fellows) in Medicine, Engineering, and Health Sciences interested in the public policy landscape shaping science, innovation, and discovery.

Program Description

This program explores how public policies shape medical and biological engineering. You will have the opportunity to hear from regulatory agencies such as the Food and Drug Administration (FDA) and the National Institute of Health (NIH). You will listen to policy experts and thought leaders explain the ramifications of proposed regulatory and policy initiatives. You will attend sessions taught by industry giants in the medical device and innovation sector. You will meet with government decision makers developing the public policies that govern patents, medical devices, pharma, and health and science legislation. You will network with early career participants in health and engineering across the nation.

By the end of the Institute, participants will be able to:

  • Describe the current regulatory science framework and its role in the decision-making about the risks and benefits of medical products.
  • Describe federal health policy initiatives that shape research and funding decisions
  • Understand the role of the executive and legislative branches in developing policies governing the scientific enterprise
  • Identify hot button issues in regulatory policy and health policy
  • Identify the numerous stakeholders shaping public health in Washington, affecting the nation

Highlighted Sessions:

  • The Role of Diplomacy in Science: Andrew Hebbeler, Ph.D., Deputy Director for Science and Technology Cooperation at U.S. Department of State
  • Vision for Regulatory Science at FDA: Ed Margerrison, Ph.D., Director, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, FDA
  • The Role of Coalitions and Associations in the Policy Process: Tannaz Rasouli, MPH, Director of Public Policy and Strategic Outreach, Association of American Medical Colleges
  • A Look Inside Federal Government Careers for Scientists: Grace Peng, Ph.D., Director of Computational Modeling, Simulation and Analysis, National Institute of Biomedical Imaging and Bioengineering (NIBIB)
  • Misuse or Subjugation of Science in Public Policy: Genna Reed, Lead Science and Policy Analyst, Center for Science and Democracy, Union of Concerned Scientists
  • Science Policy vs. Science for Policy: Tobin Smith, Vice President for Policy, Association of American Universities
  • Women’s Health, Health Policy, and the FDA: Susan Wood, Ph.D., Professor of Health Policy and Director, Jacobs Institute of Women’s Health, George Washington University
  • Policy Issues Facing the National Institutes of Health (NIH): Adrienne Hallett, Director of NIH Office for Legislative Policy & Analysis
  • Careers in Science Policy: Yvette Seger, Ph.D., Directory of Science Policy, Federal of American Societies for Experimental Biology (FASEB)
  • Best Practices for Communicating with Congress: Emily Therese Cloyd, Center for Public Engagement with Science and Technology, American Association for the Advancement of Science (AAAS)
  • What You Need to Know about Health Policy: Beth Linas, Ph.D., Department of Clinical Quality & Informatics, Health Technical Center, The MITRE Corporation


Space is extremely limited to encourage open discussion and networking. Registration will close once the event reaches capacity; early registration is encouraged to reserve your space. Registration is available at the top of the page.

Meeting Location

Alston & Bird LLP

950 F Street NW, 2nd floor conference room    

Washington, DC 20004

Hotel Information

AIMBE does not reserve a block of rooms for the Policy Institute. Listed below are several hotels near the meeting location, where the Institute will take place. The meeting location is across from the Gallery Place/Chinatown Metro stop on the Red, Green, and Yellow lines. For more information about traveling to and from the meeting location, please see their website.

Courtyard Washington Convention Center (closest hotel)
900 F St NW, Washington, DC 20004
Phone: (202) 638-4600

Renaissance Washington, DC  (.04 mile, 8 minute walk)
999 9th St NW, Washington, DC 20001
Phone: (202) 898-9000

Marriott Fairfield Inn & Suites (.05 mile, 11 minute walk)
500 H St NW, Washington, DC 20001
Phone: (202) 289-5959 


Contact Sarah Mandell, AIMBE Director of Public Policy and Strategic Partnerships